Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Known as: Metastatic Non-Squamous Non-Small Cell Lung Cancer 
A non-squamous non-small cell carcinoma that arises from the lung and has metastasized to another anatomic site.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BackgroundDelta-like ligand 4-Notch (DLL4-Notch) signaling contributes to the maintenance of chemotherapy-resistant cancer stem… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
2015
2015
Toxic epidermal necrolysis (TEN) is a rare acute life-threatening mucocutaneous disorder that is mostly drug-related (80%–95… Expand
2015
2015
OBJECTIVES To compare the activity and tolerance of the consecutive administration of four active chemotherapeutic agents in… Expand
2014
2014
INTRODUCTION Pemetrexed and erlotinib have been approved as second-line monotherapy for locally advanced or metastatic non-small… Expand
2014
2014
Background:This study evaluated the efficacy and safety of ziv-aflibercept in combination with cisplatin and pemetrexed in non… Expand
  • table 2
  • table 1
  • figure 1
  • table 3
2014
2014
BACKGROUND In the Iressa Pan-ASia Study (IPASS), gefitinib claimed improved progression-free survival (PFS) versus carboplatin… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2013
2013
8095 Background: Bavituximab (B) is a monoclonal antibody against phosphatidylserine (PS) with a selective tumor vascular… Expand
2013
2013
Pemetrexed is a folate antimetabolite approved for the treatment of mesothelioma and locally advanced or metastatic non-squamous… Expand
Highly Cited
2012
Highly Cited
2012
EGFR tyrosine kinase inhibitors (EGFR-TKIs) are recommended as first-line therapy in patients with advanced, recurrent, or… Expand
2009
2009
e19023 Background: Bevacizumab (B), in addition to platinum-based chemotherapy, is indicated for 1st-line treatment of p with… Expand